文献速递临床试验与 GCP基础与转化研究

维拉帕米对近期发病1型糖尿病成人β细胞功能的作用

Verapamil and beta cell function in adults with recent-onset type 1 diabetes.
PubMed 文献 · Nat Med · 2018-07-09

研究针对近期发病的成人1型糖尿病患者,在标准胰岛素方案基础上加用口服维拉帕米12个月,采用随机双盲安慰剂对照2期临床试验评估疗效与安全性。维拉帕米耐受良好,并与混合餐刺激C肽曲线下面积改善相关,同时胰岛素需求增幅更低、低血糖事件更少。

要点

  • 维拉帕米在标准胰岛素方案上加用12个月耐受良好
  • 混合餐刺激C肽曲线下面积在3个月和12个月改善
  • 胰岛素需求增幅更低且低血糖事件更少

核心结论

  • 每日一次口服维拉帕米可能成为促进内源性β细胞功能、减少胰岛素需求和低血糖事件的安全有效新方法。

研究设计与样本

  • 随机双盲安慰剂对照2期临床试验(NCT02372253),在近期发病的成人1型糖尿病患者中于标准胰岛素方案基础上加用口服维拉帕米12个月,评估疗效与安全性。

主要发现

  • 维拉帕米治疗与安慰剂相比耐受良好。
  • 维拉帕米与混合餐刺激C肽曲线下面积(内源性β细胞功能指标)在3个月和12个月改善相关(预设主要终点)。
  • 次要终点包括胰岛素需求增幅更低、低血糖事件更少及达标血糖控制。

临床怎么用

  • 对近期发病的成人1型糖尿病患者,可考虑在标准胰岛素方案基础上加用每日一次口服维拉帕米,以期促进内源性β细胞功能并减少胰岛素需求与低血糖事件。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pancreatic beta cell loss is a key factor in the pathogenesis of type 1 diabetes (T1D), but therapies to halt this process are lacking. We previously reported that the approved antihypertensive calcium-channel blocker verapamil, by decreasing the expression of thioredoxin-interacting protein, promotes the survival of insulin-producing beta cells and reverses diabetes in mouse models1. To translate these findings into humans, we conducted a randomized double-blind placebo-controlled phase 2 clinical trial ( NCT02372253 ) to assess the efficacy and safety of oral verapamil added for 12 months to a standard insulin regimen in adult subjects with recent-onset T1D. Verapamil treatment, compared with placebo was well tolerated and associated with an improved mixed-meal-stimulated C-peptide area under the curve, a measure of endogenous beta cell function, at 3 and 12 months (prespecified primary endpoint), as well as with a lower increase in insulin requirements, fewer hypoglycemic events and on-target glycemic control (secondary endpoints). Thus, addition of once-daily oral verapamil may be a safe and effective novel approach to promote endogenous beta cell function and reduce insulin requirements and hypoglycemic episodes in adult individuals with recent-onset T1D.

来源:Nat Med,查看原文。版权归原作者所有。

引用

  1. Ovalle F, Grimes T, Xu G, et al. Verapamil and beta cell function in adults with recent-onset type 1 diabetes. Nat Med. 2018. PMID: 29988125. doi:10.1038/s41591-018-0089-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。